Log in

Relevant bibliographies by topics / Jan Aushadhi Scheme (JAS) / Journal articles

To see the other types of publications on this topic, follow the link: Jan Aushadhi Scheme (JAS).

Journal articles on the topic 'Jan Aushadhi Scheme (JAS)'

Author: Grafiati

Published: 5 June 2025

Last updated: 1 August 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 36 journal articles for your research on the topic 'Jan Aushadhi Scheme (JAS).'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Anandhasayanam, A., S. Kannan, and R. Rajamurugan. "A pharmacoeconomic study on Jan Aushadhi generics versus branded pharmaceutical formulations in India." Indian Journal of Community Health 36, no. 3 (2024): 478–84. http://dx.doi.org/10.47203/ijch.2024.v36i03.023.

Full text

Abstract:

Background: Healthcare costs are a major burden on the society of developing countries like India. Countries like India try to limit healthcare costs in support of generic medicine. So, the Indian government initiated the Jan Aushadhi scheme in 2008 to provide high-quality generic medication at a low cost. Aim: The aim of the study was to compare the cost difference between Jan Aushadhi generic pharmaceutical formulations and branded medications in Tamil Nadu. Settings and Design: Pharmaco economic - Cost minimization observational study. Methods and Material: Study Duration: Five months, from

APA, Harvard, Vancouver, ISO, and other styles

2

Mahadkar, Pankaj U., Megha S. Mane, and Samruddhi S. Vichare. "Evaluation of brand, ceiling and generic price differences in anti-epileptic drugs marketed in India: a novel cost variation analysis." International Journal of Basic & Clinical Pharmacology 14, no. 4 (2025): 556–64. https://doi.org/10.18203/2319-2003.ijbcp20251842.

Full text

Abstract:

Background: Epilepsy affects 6–10 million people in India, where over 60% of healthcare spending is out-of-pocket. Wide price differences in branded antiepileptic drugs (AEDs) can hinder adherence and increase financial burden. While DPCO sets ceiling prices and Jan Aushadhi offers low-cost generics, no Indian study has compared AED prices across both schemes. To assess price variation among 17 commonly used AEDs and compare brand prices with DPCO ceilings and Jan Aushadhi rates. Methods: A cross-sectional cost analysis was conducted using MRPs from the Current Index of Medical Specialties, NP

APA, Harvard, Vancouver, ISO, and other styles

3

Mehak, Chandhok*1 Sarita Gautam2. "Effectiveness, Accessibility, Affordability, Availability, and Customer Satisfaction of Generic Medicines in Pradhan Mantri Jan Aushadhi Yojana." International Journal in Pharmaceutical Sciences 2, no. 4 (2024): 153–60. https://doi.org/10.5281/zenodo.10913039.

Full text

Abstract:

Jan Aushadhi Scheme was launched in November 2008 by the Department of medicinal, Ministry of Chemicals and Diseases, Government of India. Only 80 ‘Jan Aushadhi Stores’ were in operation in some states till May 2014. The Government revamped ‘Jan Aushadhi Scheme as ‘Pradhan Mantri Jan Aushadhi Yojana’ (PMJAY) in September 2015. It was renamed the Pradhan Mantri Jan Aushadhi Pariyojana. (PMBJP) to increase the scheme's appeal. This research explores the Pradhan Mantri Jan Aushadhi Yojana (PMJAY) and its impact on im-proving healthcare drug accessibility, affordabili

APA, Harvard, Vancouver, ISO, and other styles

4

Rupesh, Rastogi, and Kumar Virendra. "Pradhan Mantri Bhartiya Jan Aushadhi Yojana: Benefit to common man." RESEARCH REVIEW International Journal of Multidisciplinary 03, no. 05 (2018): 98–102. https://doi.org/10.5281/zenodo.1253416.

Full text

Abstract:

Generally people buy medicines of reputed brands or which are prescribed by their Doctors. The price of reputed brand medicines generally remains on higher side and creates affordability issue. The “Jan Aushadhi” was launched by the Govt. of India in the year 2008 with an intention of providing quality generic medicines at an affordable price. In Amritsar city of Punjab State the first “Jan Aushadhi Medical Store” was opened on 25 November 2008. The “Jan Aushadhi” was renamed “as Pradhan Mantri Bhartiya Janaushadhi Pariyojana" (PMBJP) in November

APA, Harvard, Vancouver, ISO, and other styles

5

Vasisht, Pranav V. "A study on the price variability of branded medicines and Jan aushadi versions of selected commonly prescribed psychiatric medications in India using a cost-comparative approach and a passive evaluation of the Jan aushadhi scheme in India." Journal of Family Medicine and Primary Care 13, no. 5 (2024): 2054–59. http://dx.doi.org/10.4103/jfmpc.jfmpc_1737_23.

Full text

Abstract:

ABSTRACT Introduction: The cost of medications poses a significant financial burden on patients. It limits access and adherence to treatment. Psychiatric disease burden is rising and it needs treatment for long durations. The high cost of branded medicines and lack of access to medicines at affordable prices can limit adherence. Methodology: A cost comparison study was done to investigate the price difference between branded and Jan aushadhi versions of 20 selected psychiatric drugs was done at the Department of Community Medicine of a Government medical college in Southern India. The average

APA, Harvard, Vancouver, ISO, and other styles

6

Sadiq, Shamiya, Vijay Khajuria, and Kanika Khajuria. "Knowledge, attitude, and practices toward Jan Aushadhi scheme." National Journal of Physiology, Pharmacy and Pharmacology 7, no. 9 (2017): 1. http://dx.doi.org/10.5455/njppp.2017.7.0514113052017.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Somya, Gupta, K. Bouddh Surendra, and Kale B.P. "Generic Oral Hypoglycaemic Drugs of the Jan Aushadhi Scheme in India and their Branded Counterparts: A Cost Comparison Study." International Journal of Pharmaceutical and Clinical Research 16, no. 9 (2024): 265–72. https://doi.org/10.5281/zenodo.13887040.

Full text

Abstract:

<strong>Background: </strong>India grapples with a rising diabetes burden, prompting concern over treatment costs. The Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) aims to provide affordable generic medicines, particularly for underprivileged populations. <strong>Aim: </strong>This study compares Jan Aushadhi generic antidiabetic drugs with branded counterparts to analyze cost discrepancies and their impact on treatment expenses. <strong>Methods: </strong>Prices of Jan Aushadhi generics and branded drugs were compared, revealing substantial variations. Cost r

APA, Harvard, Vancouver, ISO, and other styles

8

Mukherjee, Kanchan. "A Cost Analysis of the Jan Aushadhi Scheme in India." International Journal of Health Policy and Management 6, no. 5 (2017): 253–56. http://dx.doi.org/10.15171/ijhpm.2017.02.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Naimisha, U., and A. Ashritha. "Janaushadhi Database Management System." International Journal of Trend in Scientific Research and Development 3, no. 5 (2019): 611–17. https://doi.org/10.5281/zenodo.3590887.

Full text

Abstract:

The pharmaceutical industry has evolved from merely Rs.1500 crores in 1980 to more than Rs.1,19,000 crores by 2012. Medicines in almost every therapeutic category are sold primarily as branded drugs, at disproportionately very high prices.80 of out patient care and 60 of all in hospital care occurs at private facilities in India and majority of households are exposed to a private sector market to buy drugs. According to NSO estimates, up to 79 of health care expenses in rural areas are due to the cost of medicines. Thus, access to low priced generic drugs is very critical in ensuring health ca

APA, Harvard, Vancouver, ISO, and other styles

10

Kaul, Evesh, and Priyanka Gupta. "Survey of the Jan Pariyojana Scheme in India and its impact on citizens during the previous decade." International Journal of Drug Regulatory Affairs 10, no. 4 (2022): 8–12. http://dx.doi.org/10.22270/ijdra.v10i4.537.

Full text

Abstract:

It is a well-known fact that Branded medicines are sold at significantly higher prices in India. Making affordable, high-quality pharmaceuticals available on the market will help everyone, but mainly the underprivileged and destitute given the country's pervasive poverty. The Indian government has always been quite concerned about this. The Ministry of Chemicals and Fertilizers' Department of Pharmaceutical has periodically implemented a number of regulatory and financial initiatives to achieve this goal. The "Pradhan Mantri Bhartiya Jan Aushadhi Pariyojana" is a wonderful project starte

APA, Harvard, Vancouver, ISO, and other styles

11

Pareek, Manoj, and M. Dr. Prakash. "Providing generic medicines to the poor in India: An overall assessment of government-run generic medicine scheme Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) with reference to the experience of store owners in the city of Jaipur." International Journal of Pharmaceutical Research 11, no. 2 (2019): 32–37. https://doi.org/10.5281/zenodo.2669542.

Full text

Abstract:

Out of Pocket expenditure on medicines constitutes more than 50% of healthcare expenditure in India. The poor are most affected as branded medicines are expensive and treatments involving the use of such medicines pushes them further into poverty.To address this issue government central government started Jan Aushadhi (Medicine for the masses) programme in 2008 with the objective of providing quality medicines at affordable prices. The programme envisaged the sale of generic medicines through stores to be called "Pradhan Mantri Janaushadhi Kendras” in various districts of the countr

APA, Harvard, Vancouver, ISO, and other styles

12

Shaik, Reena, and Pradeep M Muragundi. "EVALUATION OF PRICE DISPARITY AMONG GENERIC MEDICINES IN INDIA." Asian Journal of Pharmaceutical and Clinical Research 11, no. 12 (2018): 466. http://dx.doi.org/10.22159/ajpcr.2018.v11i12.28461.

Full text

Abstract:

Objective: Even though the generic medicines are considered to be a cheaper option compared to the branded medicines in India, there is a need to study the price disparity among the generic medicines. Hence, the present study aims to evaluate the price disparity in generic medicines under Government Scheme in India.Methods: It was found that there were 101 generic medicines approved at a fixed price for procurement under the Central Government Health Services scheme. The prices of these medicines were searched for their availability as well as for current price in Bureau of Pharma PSUs of Indi

APA, Harvard, Vancouver, ISO, and other styles

13

Joshi, Deeksha, Saurabh Gupta, Thakur Gurjeet Singh, Abhimanyu Prashar, Swati Gauniyal, and Sachin Singh. "A study of various existing interventions for the treatment of hypertension in the Indian market under the Jan Aushadhi Scheme: A price control aspect for consideration by Journal of Health Policy & Outcomes Research." Journal of Health Policy & Outcomes Research, no. 1 (June 29, 2022): 37–52. http://dx.doi.org/10.7365/jhpor.2022.1.4.

Full text

Abstract:

Aim: Analysis of the percentage price differences among the widely prescribed antihypertensive drugs available on the Indian retail market and under the Pradhan Mantri Bhartiya Jan Aushadhi Pariyojana (PMBJP) or the Jan Aushadhi scheme. Materials and Methods: The prices of frequently prescribed various antihypertensive brands were collected and organized by using latest Monthly Index of Medical Specialties. The price of 1 dosage form in INR of each brand was extracted. Based on the price of various brands, average price of each drug was calculated and compared with the price of PMBJP drugs. Ad

APA, Harvard, Vancouver, ISO, and other styles

14

Bhattacharjee, Prithul, Lakshman Das, Ranjib Ghosh, Uttam K. Das, and Maitrayee Chakraborty. "Knowledge, attitude and practice of generic medicines among doctors in a tertiary care teaching hospital of Tripura, India." International Journal of Basic & Clinical Pharmacology 6, no. 6 (2017): 1287. http://dx.doi.org/10.18203/2319-2003.ijbcp20172040.

Full text

Abstract:

Background: The assessment of doctors’ perceptions and understanding about generic medicines may help in recognizing possible barriers to greater generic medicine usage. The primary objective of this study was to explore the knowledge, attitude, and practice (KAP) of doctors toward generic medicines.Methods: A questionnaire based cross-sectional study was carried out in a tertiary-care teaching hospital of Tripura. The questionnaire was designed to assess the KAP about generic medicines. The doctors working in this institute during the study period were included. All data were analysed using s

APA, Harvard, Vancouver, ISO, and other styles

15

Ballala, Kirthinath, Chythra R. Rao, Aparna S. Chaudhary, Ashwini S. Bidnurmath, and Akhilesh K. Pandey. "Knowledge, attitude and practices regarding generic medicines and its usage: a community-based study." International Journal Of Community Medicine And Public Health 6, no. 5 (2019): 2182. http://dx.doi.org/10.18203/2394-6040.ijcmph20191841.

Full text

Abstract:

Background: India is the largest provider of generic medications globally. Despite this, several essential medicines remain inaccessible to majority of the general population, due to poor awareness, unavailability of drugs, distrust about the quality of the medicines, poor policy implementation and inadequate recommendation by doctors.Methods: A community-based cross-sectional study was carried out among 1151 adults in rural and urban areas attached to the community outreach area of a University Medical College. Written informed consent was taken from the participants. Data was collected using

APA, Harvard, Vancouver, ISO, and other styles

16

Prasad T, Aditya. "Jan Aushadi Scheme: A Crucial Step Towards Achieving Health Equity." Journal of Learning and Educational Policy, no. 23 (May 17, 2022): 33–40. http://dx.doi.org/10.55529/jlep.23.33.40.

Full text

Abstract:

To effectively promote generic medicine use in the country, it is evident that the central policy of the Jan Aushadi Scheme needs to be supported by complementary policies and initiatives to overcome the significant barriers and facilitate its implementation. To this outcome, keeping in line with the discussion above, the paper provides recommendations on improving four target determinants – Trust, Value, Convenience, and Policy reform.

APA, Harvard, Vancouver, ISO, and other styles

17

T, Aditya Prasad. "Jan Aushadi Scheme: A crucial step towards achieving health equity." Journal Healthcare Treatment Development, no. 23 (May 16, 2022): 6–13. http://dx.doi.org/10.55529/jhtd23.6.13.

Full text

Abstract:

Health Equity is a widely acknowledged policy objective for all responsible governments around the world. Equity refers to “equal access to available care for equal need, equal utilization for equal need, and equal quality of care for all” (Whitehead, 1992). Simply put, Health Equity is about ensuring that every person has the chance to be as healthy as possible. In this context, access to affordable medicines becomes a crucial component towards attaining equity, as even today, drugs constitute a high proportion of out-of-pocket (OOP) expenses, often causing untold financial hardships for most

APA, Harvard, Vancouver, ISO, and other styles

18

Manjula Bai, H. "A Study on Customer Awareness towards Pradhan Mantri Bharatiya Jnanaushadi Kendra’s with Reference to Shimoga." ComFin Research 9, no. 1 (2021): 1–10. http://dx.doi.org/10.34293/commerce.v9i1.3257.

Full text

Abstract:

This paper is designed to check Customer Awareness towards Pradhan Mantri Bharatiya Jnanaushadi Kendra’s. This study is finished to understand the knowledge, perception and attitude of individuals and patients towards generic medicines provided by the govt. At low cost through Jan Aushadhi Medical Stores, which supports and helps the people below the personal income. This helps to spot the problems faced by people and also helps to make your mind up and to relinquish solutions regarding the matter that, not every-one is aware of the schemes implemented by the govt. For the welfare of the peopl

APA, Harvard, Vancouver, ISO, and other styles

19

Pramod Kumar, T. M., and S. H. Chalasani. "PNS26 JAN AUSHADI SCHEME: AN INITIATIVE IN MAKING QUALITY GENERIC MEDICINES AT AFFORDABLE PRICES." Value in Health 22 (May 2019): S291. http://dx.doi.org/10.1016/j.jval.2019.04.1390.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Krishna, Abhishek, Paul Simon, Princy L. Palatty, et al. "Cost analysis of anticancer chemotherapy and chemoirradiation regimens considering the drugs marketed through Jan Aushadhi (People’s Medicine) stores and their branded counterparts: First cost comparison study." Journal of Cancer Research and Therapeutics 20, no. 5 (2024): 1472–85. http://dx.doi.org/10.4103/jcrt.jcrt_2387_22.

Full text

Abstract:

ABSTRACT Introduction: Chemotherapy in an integral part of cancer treatment, either administered alone or in combination with radiation. However, the cost of these drugs is often prohibitively high for most patients. To address this issue, the Government of India has established Jan Aushadhi (JAS) stores across the country, where affordable generic medicines are available. In the current study, we performed a cost minimization analysis comparing JAS drugs with branded chemotherapeutic drugs used in various cancer treatment regimens. Objectives: This study was to conduct a cost-minimization ana

APA, Harvard, Vancouver, ISO, and other styles

21

"Impact of Brand Awareness and Customer Satisfaction Towards Services of Jan Aushadhi Medicalstores." International Journal of Recent Technology and Engineering 8, no. 2S4 (2019): 546–51. http://dx.doi.org/10.35940/ijrte.b1107.0782s419.

Full text

Abstract:

This study focused on ‘Jan Aushadhi Scheme’ launched by the government of India. It is the need of the hour to understand the knowledge level of the consumer about generic medicine to promote the product and services across the various region in India. The purpose of the study is to identify the service of the stores by way of assessing service quality, brand awareness and customer satisfaction to offer suitable marketing strategies to the Jan Aushadi Medical Stores.

APA, Harvard, Vancouver, ISO, and other styles

22

-, Nisha Bhambure, Dr Vandana Yadav -, and Dr Rajiv Gatne -. "Pradhan Mantri Bharatiya Jan Aushadi Pariyojana – An Evaluation of Jan Aushadhi Kendra in Mumbai Metropolitan Region." International Journal For Multidisciplinary Research 6, no. 3 (2024). http://dx.doi.org/10.36948/ijfmr.2024.v06i03.20588.

Full text

Abstract:

Affordable healthcare remains a significant challenge for many low and middle-income countries, with the cost of medicines constituting a substantial portion of patients' expenses. Despite the implementation of various policy changes aimed at addressing this issue, the expenditure on drugs continues to represent a significant proportion of out-of-pocket healthcare costs. In a country like India, where both state and central governments have implemented policies to mitigate this burden, the uptake of generic drugs, which could significantly reduce spending, has not been effectively promoted. Th

APA, Harvard, Vancouver, ISO, and other styles

23

Sareen, Ashutosh, Gurvinder Singh, Sheetu Wadhwa, Navneet Khurana, and Rajesh Kumar. "Awareness regarding generic and ethical medicines, and Jan Aushadhi Kendra: A survey-based study." Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector, August 3, 2022, 174113432211158. http://dx.doi.org/10.1177/17411343221115807.

Full text

Abstract:

Background Increased healthcare charges remain a prime subject worldwide, especially in underdeveloped and developing countries like India, where economic conditions are on the lower side. To control this, the Government of India (GoI) launched Jan Aushadhi scheme in April 2008 for providing low-cost generic medicines, however, the scheme has not been able to reach an extent. Moreover, the patients rely on branded prescribed medicines due to a lack of awareness. India is the world’s largest maker of generic medicines since its pharmaceutical sector fulfils over 50% of the global demand, still,

APA, Harvard, Vancouver, ISO, and other styles

24

Solanki, Kavita. "Exploring the differences between socio-economic groups to know their perspective and mind set about generic medicines." International journal of health sciences, June 9, 2022. http://dx.doi.org/10.53730/ijhs.v6ns3.8739.

Full text

Abstract:

Medicines comprise an important element in healthcare, providing protection, restoring and maintaining people’s wellbeing. Then the availability and excess of appropriate medicines of accrued quality, and quantities at reasonable prices are thus, a concern of global and national policymakers, health agencies and organizations. Pharmaceuticals and medicines form a sizeable outer pocket expenditure of health in Indian households. In the context of providing universal health care, providing financial risk protection to households affected by illness is a key objective with a focus on providing co

APA, Harvard, Vancouver, ISO, and other styles

25

Vijaya, Kumar G., Suranjan Bantupalli, Yaswanth Kumar S. Bala, Deekshit Atluri, and Vijaya Durga Akula. "Perception of rural and urban population on generic and branded drugs." October 9, 2021. https://doi.org/10.26452/fjphs.v1i4.175.

Full text

Abstract:

Generic medicines are identical/ clone to an innovator or product brand name. After expiration of patent terms of the innovator product, other pharmaceutical companies usually apply to the drug regulatory bodies for approval to market the generic versions of the innovator's drugs. Generic drugs in the market were sold under the non-proprietary name or brand name. Drugs and medicines form a significant portion of out of pocket (OOP) expenses in Indian households. In order to resolve this issue, Government of India launched Jan Aushadhi Scheme (JAS) to provide inexpensive generic drugs to th

APA, Harvard, Vancouver, ISO, and other styles

26

Shweta, Shweta, Dinesh Kumar, and Dheeraj Chandra. "A hybrid framework to model resilience in the generic medicine supply chain of MSMEs." Benchmarking: An International Journal, October 7, 2022. http://dx.doi.org/10.1108/bij-11-2021-0697.

Full text

Abstract:

PurposeOne of the most important components of healthcare is the timely delivery of pharmaceutical products, such as life-saving medicines. However, disruptions like COVID-19 bring new challenges and risks to the pharmaceutical supply chain (PSC) and healthcare organizations that impact their operational performance. This study focuses on mitigating risks in India's generic medicine supply chain (GMSC) as a result of various disruptions, which can assist policymakers develop appropriate plans and strategies to build resilience in the Jan Aushadhi Scheme (JAS) of micro, small and medium enterpr

APA, Harvard, Vancouver, ISO, and other styles

27

Hetawal, Pallav, Sapna More, Kamayani Gupta, and Pooja S. Mishra. "Cost Variation Study of Various Brands of Oral Fluoroquinolones Available in India: An Economic Perspective." Pharmacology and Clinical Pharmacy Research 7, no. 2 (2022). http://dx.doi.org/10.15416/pcpr.v7i2.37669.

Full text

Abstract:

Fluoroquinolones are broad-spectrum antibacterial for treating respiratory tract, intra-abdominal, urinary tract, pelvic, joint, bone, soft tissue, and skin infections. The economic burden on patients affects compliance in developing countries like India. Therefore, the prices of drugs should be controlled effectively. Hence, this study was done to assess the cost variation of branded oral fluoroquinolones available in India compared with generic counterparts. The maximum and minimum cost of oral fluoroquinolones (INR per 10 tablets) of the same strength and dosage form manufactured by differe

APA, Harvard, Vancouver, ISO, and other styles

28

Satheesh, Gautam, M. K. Unnikrishnan, and Abhishek Sharma. "Challenges constraining availability and affordability of insulin in Bengaluru region (Karnataka, India): evidence from a mixed-methods study." Journal of Pharmaceutical Policy and Practice 12, no. 1 (2019). http://dx.doi.org/10.1186/s40545-019-0190-1.

Full text

Abstract:

Abstract Introduction Considering limited global access to affordable insulin, we evaluated insulin access in public and private health sectors in Bengaluru, India. Methods Employing modified WHO/HAI methodology, we used mixed-methods analysis to study insulin access and factors influencing insulin supply and demand in Bengaluru in December 2017. We assessed insulin availability, price and affordability in a representative sample of 5 public-sector hospitals, 5 private-sector hospitals and 30 retail pharmacies. We obtained insulin price data from websites of government Jan Aushadhi scheme (JAS

APA, Harvard, Vancouver, ISO, and other styles

29

George, Thomas, and Manjeshwar S. Baliga. "Generic Anticancer Drugs of the Jan Aushadhi Scheme in India and Their Branded Counterparts: The First Cost Comparison Study." Cureus, November 3, 2021. http://dx.doi.org/10.7759/cureus.19231.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Prakash, Gnana. "Perception of rural and urban population on generic and branded drugs." Future Journal of Pharmaceuticals and Health Sciences 1, no. 4 (2021). http://dx.doi.org/10.26452/fjphs.v1i4.175.

Full text

Abstract:

Generic medicines are identical/ clone to an innovator or product brand name. After expiration of patent terms of the innovator product, other pharmaceutical companies usually apply to the drug regulatory bodies for approval to market the generic versions of the innovator's drugs. Generic drugs in the market were sold under the non-proprietary name or brand name. Drugs and medicines form a significant portion of out of pocket (OOP) expenses in Indian households. In order to resolve this issue, Government of India launched Jan Aushadhi Scheme (JAS) to provide inexpensive generic drugs to the pa

APA, Harvard, Vancouver, ISO, and other styles

31

Lavtepatil, Sonam, and Soumitra Ghosh. "Improving access to medicines by popularising generics: a study of ‘India’s People’s Medicine’ scheme in two districts of Maharashtra." BMC Health Services Research 22, no. 1 (2022). http://dx.doi.org/10.1186/s12913-022-08022-1.

Full text

Abstract:

Abstract Background In spite of being the ‘pharmacy of the world’, access to essential medicines for a large majority of Indians is constrained by both physical and financial reasons. According to an estimate, medicines account for 69% of household out-of-pocket spending on health care. To make quality generic medicine affordable, India’s People’s Medicine Scheme (Jan Aushadhi) was launched in 2008 and then revamped and rebranded as Pradhan Mantri Bhartiya Jan Ausadhi Pariyojana (PMBJP) in 2015. The current study focuses on the availability, affordability and acceptability aspects of PMBJP ess

APA, Harvard, Vancouver, ISO, and other styles

32

Mondal, Nabanita, Supreetha Castelino, and John Varghese. "A Study to Assess The Knowledge and Practice of Healthcare Workers and The General Public About Generic and Branded Medicine In Bengaluru." RGUHS Journal of Allied Health Sciences 4, no. 1 (2024). http://dx.doi.org/10.26463/rjahs.4_1_3.

Full text

Abstract:

Background A generic drug is a pharmaceutical drug that contains the same chemical substance as a drug that was originally protected by chemical patents. The Indian government launched a project called the Jan Aushadhi Scheme to provide low-income people with unbranded quality medicines at affordable prices.Objective The study aimed to assess the knowledge and practice of healthcare workers and the general public about generic and branded drugs.Methodology It was a questionnaire-based cross-sectional study done with 150 respondents each from the general public and healthcare workers using a co

APA, Harvard, Vancouver, ISO, and other styles

33

T, Aditya Prasad. "Jan Aushadi Scheme: A crucial step towards achieving health equity." Journal Healthcare Treatment Development, May 16, 2022, 15–22. http://dx.doi.org/10.55529/jhtd.23.15.22.

Full text

Abstract:

Health Equity is a widely acknowledged policy objective for all responsible governments around the world. Equity refers to “equal access to available care for equal need, equal utilization for equal need, and equal quality of care for all” (Whitehead, 1992). Simply put, Health Equity is about ensuring that every person has the chance to be as healthy as possible. In this context, access to affordable medicines becomes a crucial component towards attaining equity, as even today, drugs constitute a high proportion of out-of-pocket (OOP) expenses, often causing untold financial hardships for most

APA, Harvard, Vancouver, ISO, and other styles

34

T, Aditya Prasad. "Jan Aushadi Scheme: A crucial step towards achieving health equity." Journal of Prevention, Diagnosis and Management of Human Diseases, October 25, 2021, 1–9. http://dx.doi.org/10.55529/jpdmhd.12.1.9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Prasad T, Aditya, and Ashwani Panesar. "Decoding the perception of prescribers towards generic medicine: A bibliometric study." Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector, January 24, 2024. http://dx.doi.org/10.1177/17411343231226122.

Full text

Abstract:

2008 can be considered a watershed year for generic medicine in India, as it saw the launch of the Jan Aushadi scheme, to provide cost-effective quality medicines to its populace, through special stores called Jan Aushadi stores. With more than 8800 stores, the scheme is touted as one of the world’s largest pharmaceutical retail chains. Since then, many generic medicine start-ups have also launched operations in the country- Zeno Health, One India Pharmacy, Generic Aadhaar and StayHappi Generics. These supply side developments will however have to be complemented with commensurate demand side

APA, Harvard, Vancouver, ISO, and other styles

36

Payal, Billu, Anoop Kumar, and Harsh Saxena. "Cost-minimization analysis of drugs used in the treatment of Asthma and COPD diseases in India." Current Drug Therapy 15 (August 13, 2020). http://dx.doi.org/10.2174/1574885515999200813193250.

Full text

Abstract:

Background: Asthma and Chronic Obstructive Pulmonary Diseases (COPD) are well known respiratory diseases affecting millions of peoples in India. In the market, various branded generics, as well as generic drugs, are available for their treatment and how much cost will be saved by utilizing generic medicine is still unclear among physicians. Thus, the main aim of the current investigation was to perform cost-minimization analysis of generic versus branded generic (high and low expensive) drugs and branded generic (high expensive) versus branded generic (least expensive) used in the Department o

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!